Pierre‐françois Plouin

Pierre‐françois Plouin's AcademicInfluence.com Rankings

Medical

#3313

World Rank

#3780

Historical Rank

Cardiology

#344

World Rank

#355

Historical Rank

medical Degrees

Pierre‐françois Plouin

Philosophy

#9481

World Rank

#13047

Historical Rank

Logic

#6454

World Rank

#7972

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Pierre‐françois Plouin's Degrees

Doctorate Medicine Université Paris Cité
PhD Cardiology Université Paris Cité

Why Is Pierre‐françois Plouin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Pierre‐françois Plouin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. (2005) (1384)
Genetic testing in pheochromocytoma or functional paraganglioma. (2005) (621)
Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. (2006) (537)
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. (2003) (513)
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension (2013) (464)
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial (2015) (434)
Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. (2009) (433)
An Expert Consensus Statement on Use of Adrenal Vein Sampling for the Subtyping of Primary Aldosteronism (2014) (403)
Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. (2007) (372)
Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study (2013) (369)
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. (2001) (357)
The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. (2009) (347)
Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. (2005) (331)
Masked hypertension: a systematic review. (2008) (297)
The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. (2012) (293)
Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. (2001) (291)
MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma (2012) (284)
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. (2011) (277)
SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. (2011) (270)
Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism (2012) (242)
Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. (1997) (235)
The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas (2009) (225)
Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy. (2005) (223)
Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. (2002) (206)
Efficacy of Revascularization For Renal Artery Stenosis Caused by Fibromuscular Dysplasia: A Systematic Review and Meta-Analysis (2010) (206)
Blood pressure loci identified with a gene-centric array. (2011) (177)
KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism (2012) (171)
European consensus on the diagnosis and management of fibromuscular dysplasia. (2014) (165)
Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas (2015) (160)
Gene polymorphisms of the renin‐angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study (1998) (152)
Fibromuscular Dysplasia of Cervical and Intracranial Arteries (2010) (152)
Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. (2003) (150)
WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. (2014) (149)
Phaeochromocytoma, new genes and screening strategies (2006) (147)
A clinical prediction score to diagnose unilateral primary aldosteronism. (2012) (147)
Validation of a French Version of the 8‐Item Morisky Medication Adherence Scale in Hypertensive Adults (2012) (146)
Aldosterone Synthase Inhibition With LCI699: A Proof-of-Concept Study in Patients With Primary Aldosteronism (2010) (141)
Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. (2002) (139)
Sequential nephron blockade versus sequential renin–angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study (2012) (136)
PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance (2016) (136)
Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas. (2010) (136)
[Diagnosis and classification of diabetes mellitus: the new criteria]. (1999) (133)
First international consensus on the diagnosis and management of fibromuscular dysplasia. (2019) (129)
Possible familial origin of multifocal renal artery fibromuscular dysplasia (1997) (128)
Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators. (2013) (126)
Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. (2004) (122)
Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial (2016) (122)
Adrenal Cortex Remodeling and Functional Zona Glomerulosa Hyperplasia in Primary Aldosteronism (2010) (120)
Association Between 2 Angiographic Subtypes of Renal Artery Fibromuscular Dysplasia and Clinical Characteristics (2012) (116)
Diabetes as a marker of pheochromocytoma in hypertensive patients (2003) (115)
Fasting Plasma Glucose and Serum Lipids in Patients With Primary Aldosteronism: A Controlled Cross-Sectional Study (2009) (113)
Treatment of malignant pheochromocytoma. (2009) (112)
Diagnosis and management of fibromuscular dysplasia: an expert consensus (2012) (111)
High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia) (2017) (107)
Metastatic Pheochromocytoma and Paraganglioma: Focus on Therapeutics (2012) (106)
First International Consensus on the diagnosis and management of fibromuscular dysplasia (2019) (104)
Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. (2009) (103)
Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma (2008) (101)
Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma (2013) (101)
Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases. (2003) (100)
Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma. (2010) (96)
Blood pressure and renal outcomes in patients with kidney infarction and hypertension (2006) (95)
Comparison of nurse‐ and physician‐determined clinic blood pressure levels in patients referred to a hypertension clinic: implications for subsequent management (2000) (92)
Inheritance of arterial lesions in renal fibromuscular dysplasia (2007) (92)
One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma. (2013) (91)
Pheochromocytomas and secreting paragangliomas (2006) (90)
Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial (1988) (89)
The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design. (2003) (89)
Renin secreting tumors: diagnosis, conservative surgical approach and long-term results. (1995) (89)
Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations. (2012) (86)
Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers. (2011) (84)
The Urinary Metanephrine-to-Creatinine Ratio for the Diagnosis of Pheochromocytoma (1996) (84)
Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma. (1993) (84)
Factors predictive of attendance at clinic and blood pressure control in hypertensive patients. (1983) (79)
Angiotensin‐converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril (1988) (78)
Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism (2010) (73)
Rationale for Anti-angiogenic Therapy in Pheochromocytoma and Paraganglioma (2012) (73)
Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations. (1981) (72)
Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis. (2001) (72)
TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma. (2012) (69)
Revisiting Fibromuscular Dysplasia: Rationale of the European Fibromuscular Dysplasia Initiative. (2016) (63)
Association of Smoking With Phenotype at Diagnosis and Vascular Interventions in Patients With Renal Artery Fibromuscular Dysplasia (2013) (62)
Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy. (2007) (61)
[Screening for phaeochromocytoma : in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl)]. (1981) (60)
Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors. (2003) (59)
Benefits of a computer-assisted education program for hypertensive patients compared with standard education tools. (1994) (58)
Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients. (2012) (55)
RECENT ADVANCES IN THE GENETICS OF PHAEOCHROMOCYTOMA AND FUNCTIONAL PARAGANGLIOMA (2008) (54)
Structural analysis and evaluation of the 11β‐hydroxysteroid dehydrogenase type 2 (11β‐HSD2) gene in human essential hypertension (1998) (54)
Initial work-up and long-term follow-up in patients with phaeochromocytomas and paragangliomas. (2006) (52)
Spontaneous renal artery dissection: long-term outcomes after endovascular stent placement. (2009) (51)
Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas. (2005) (50)
Influence of Diagnostic Criteria on the Interpretation of Adrenal Vein Sampling (2015) (49)
A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma. (2011) (49)
Differences in emotion processing in patients with essential and secondary hypertension. (2010) (47)
Gene expression profiling of human adrenocortical tumors using cDNA microarrays identifies several candidate genes as markers of malignancy (2004) (47)
HYPERTENSIVE CRISIS IN PATIENT WITH PHÆOCHROMOCYTOMA GIVEN METOCLOPRAMIDE (1976) (47)
Effects of slow‐release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma (2002) (47)
Disruption of the elastin gene in adult Williams syndrome is accompanied by a paradoxical reduction in arterial stiffness. (2002) (47)
Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases (2008) (46)
Renal artery stent placement: immediate and midterm technical and clinical results. (1994) (46)
Fibromuscular dysplasia (2007) (46)
CYCLOSPORINE‐INDUCED STIMULATION OF THE RENIN‐ANGIOTENSIN SYSTEM AFTER LIVER AND HEART TRANSPLANTATION (1993) (45)
Short‐term effects of octreotide on blood pressure and plasma catecholamines and neuropeptide Y levels in patients with phaeochromocytoma: a placebo‐controlled trial (1995) (45)
Socioeconomic Status and Hypertension Control in Sub-Saharan Africa: The Multination EIGHT Study (Evaluation of Hypertension in Sub-Saharan Africa) (2018) (42)
Blunt renal trauma-induced hypertension: prevalence, presentation, and outcome. (2006) (42)
Evidence for carotid and radial artery wall subclinical lesions in renal fibromuscular dysplasia (2003) (42)
Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism: a follow-up study (2012) (42)
Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension. (1982) (42)
Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker, acebutolol, and diuretics in essential hypertension. (1978) (41)
Fibromuscular Dysplasia and Its Neurologic Manifestations: A Systematic Review (2019) (40)
Diagnosis and treatment of renal artery stenosis (2010) (39)
The Non–Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) Study: Design, Organization, and Patient Recruitment (2000) (39)
Hypertension management: the computer as a participant. (1980) (39)
Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia (2015) (38)
MANAGEMENT OF ENDOCRINE DISEASE: Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis. (2016) (38)
Fighting fake medicines: First quality evaluation of cardiac drugs in Africa. (2017) (37)
Relative Expression of the RET9 and RET51 Isoforms in Human Pheochromocytomas (2000) (35)
SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook. (2016) (35)
α1-antitrypsin gene polymorphisms are not associated with renal arterial fibromuscular dysplasia (2006) (34)
Sequential comparison of aldosterone synthase inhibition and mineralocorticoid blockade in patients with primary aldosteronism (2013) (33)
Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas. (2015) (31)
Glucagon receptor gene mutation (Gly40Ser) in human essential hypertension: the PEGASE study. (1999) (31)
Would wider screening for primary aldosteronism give any health benefits? (2004) (31)
Atherosclerotic renovascular disease: beyond the renal artery stenosis. (2007) (30)
Hypertension and aortorenal disease in Alagille syndrome (2012) (28)
Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial (2017) (28)
Presentation and revascularization outcomes in patients with radiation-induced renal artery stenosis. (2001) (28)
Circulating EM66 is a highly sensitive marker for the diagnosis and follow‐up of pheochromocytoma (2006) (28)
Peritoneal implantation of pheochromocytoma following tumor capsule rupture during surgery. (2014) (27)
[Recent advances in the clinical study of the renin system. Reference values and conditions of validity]. (1989) (27)
Use of a standardized personal medical record by patients with hypertension: a randomized controlled prospective trial. (1995) (26)
Steroidogenesis in aldosterone-producing adenoma revisited by transcriptome analysis. (2005) (26)
Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors. (2008) (26)
Cause of renal infarction: a retrospective analysis of 186 consecutive cases (2017) (26)
Changes in Urinary Total Metanephrine Excretion in Recurrent and Malignant Pheochromocytomas and Secreting Paragangliomas (2006) (25)
The genetic basis of pheochromocytoma: who to screen and how? (2006) (25)
Development of Novel Tools for the Diagnosis and Prognosis of Pheochromocytoma Using Peptide Marker Immunoassay and Gene Expression Profiling Approaches (2006) (25)
Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension—a randomised ABPM study (2003) (25)
Phaeochromocytomas and functional paragangliomas: clinical management. (2010) (25)
[Conn's adenoma. Diagnostic and prognostic value of the measurement of potassium, renin, aldosterone levels and the aldosterone/renin ratio]. (1995) (25)
EUROPEAN SOCIETY OF HYPERTENSION EXCELLENCE CENTRES (2007) (25)
Recent developments in pheochromocytoma diagnosis and imaging. (1988) (25)
Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival. (2010) (25)
ACE inhibitors, cough, and genetics (1994) (25)
Fetal growth retardation in gestational hypertension: relationships with blood pressure levels and the time of onset of hypertension. (1983) (24)
Management of the patient with atherosclerotic renal artery stenosis. New information from randomized trials. (1999) (24)
Localization and characterization of evolutionarily conserved chromogranin A-derived peptides in the rat and human pituitary and adrenal glands (2002) (24)
Clinical management of renal artery fibromuscular dysplasia: temporal trends and outcomes (2014) (23)
Primary stenting for atherosclerotic renal artery stenosis. (2010) (23)
Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management. (2003) (22)
THE EUROPEAN/INTERNATIONAL FIBROMUSCULAR DYSPLASIA REGISTRY AND INITIATIVE (FEIRI)- CLINICAL PHENOTYPES AND THEIR PREDICTORS BASED ON A COHORT OF ONE THOUSAND PATIENTS. (2020) (21)
Assessment of serum sodium to urinary sodium divided by (serum potassium)² to urinary potassium as a screening tool for primary aldosteronism (2011) (20)
Expression and Processing of the Neuroendocrine Protein Secretogranin II in Benign and Malignant Pheochromocytomas (2006) (20)
Suppression of Aldosterone Secretion After Recumbent Saline Infusion Does Not Exclude Lateralized Primary Aldosteronism (2016) (20)
The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. DIABHYCAR Study Group. (2000) (20)
High levels of tyrosine phosphorylated proto-ret in sporadic phenochromocytomas. (2000) (20)
Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome) (2001) (20)
Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin–angiotensin blockade for left ventricular mass regression in patients with resistant hypertension (2014) (20)
[Inhibition of angiotensin converting enzyme in human pregnancy. 15 cases]. (1985) (19)
Plasma renin activity in phaeochromocytoma: effects of beta-blockade and converting enzyme inhibition. (1988) (19)
Primary adrenal angiosarcoma and functioning adrenocortical adenoma: an exceptional combined tumor. (2012) (19)
Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial. (2002) (18)
Diagnostic biochimique du phéochromocytome et du neuroblastome (2002) (18)
Risk of fetal growth retardation as a result of maternal hypertension. Preparation to a trial on antihypertensive drugs. (1982) (18)
Eligibility for Renal Denervation: Anatomical Classification and Results in Essential Resistant Hypertension (2015) (18)
Proteinuria in renal artery occlusion is related to active renin concentration and contralateral kidney size (2002) (18)
Is Primary Aldosteronism Underdiagnosed In Clinical Practice? (2001) (18)
INFLUENCE OF BLOOD SAMPLING PROCEDURE ON PLASMA CONCENTRATIONS OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS (2008) (18)
[Angiotensin II receptor blockers: current status and future prospects]. (2002) (18)
Outcomes of drug-based and surgical treatments for primary aldosteronism. (2015) (17)
Substandard drugs among five common antihypertensive generic medications: an analysis from 10 African countries (2018) (17)
How much can blood pressure be lowered? (1983) (17)
[Biochemical diagnosis of pheochromocytoma and neuroblastomas]. (2002) (17)
Frequency and perinatal consequences of hypertensive disease of pregnancy. (1986) (16)
Combination therapy with candesartan cilexetil plus hydrochlorothiazide in patients unresponsive to low-dose hydrochlorothiazide. (1997) (16)
[Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)]. (1998) (16)
The application of molecular genetics to the study of familial arterial hypertension. (1990) (15)
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis. (2016) (15)
Hypocaloric diet and antihypertensive drug treatment. A randomized controlled clinical trial. (1993) (14)
Interactive electronic teaching (ISIS): has the future started? (1996) (14)
Long-term experience of spironolactone in essential hypertension. (1988) (14)
A clinical approach to the management of a patient with suspected renovascular disease who presents with leg ischemia. (2003) (14)
[Detection, diagnosis and localization of pheochromocytoma. 77 cases in a population of 21,420 hypertensive patients]. (1987) (14)
Structural analysis and evaluation of the 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) gene in human essential hypertension. (1998) (14)
SAH gene variants are associated with obesity-related hypertension in Caucasians: the PEGASE Study (2007) (13)
Individualization of antihypertensive therapy. (1988) (13)
Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia (2020) (13)
Sex differences in antihypertensive treatment in France among 17 856 patients in a tertiary hypertension unit (2018) (13)
Factors predictive of perinatal outcome in pregnancies complicated by hypertension. (1986) (13)
Endovascular Renal Artery Denervation: Why, When, and How? (2012) (13)
[Localization of primary hyperaldosteronism]. (1988) (12)
Hypertension artérielle endocrine (2010) (12)
The Long-Term Effectiveness of Preventive Strategies for Osteoporosis in Postmenopausal Women: A Modeling Approach (2000) (12)
Cardiovascular risk factors in hypertensive patients born in Northern Africa and living in France (2010) (12)
Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma. (2015) (12)
Molecular Biology as a Tool for Genetic Research in Hypertension: Application to the Renin Gene (1988) (12)
[Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study]. (1995) (12)
Poor adherence to medication and salt restriction as a barrier to reaching blood pressure control in patients with hypertension: Cross-sectional study from 12 sub-Saharan countries. (2020) (12)
[COMETE, a network for the study and management of hypersecreting adrenal tumors]. (2008) (11)
[Hypertension in the elderly]. (2006) (10)
Simultaneous measurement of beta-endorphin, lipotrophins and met-enkephalin in phaeochromocytomas. (1982) (10)
[Recent progress in the diagnosis, prognostic evaluation and treatment of pheochromocytomas]. (2000) (9)
A6 - Short term effects of octreotide on blood pressure and plasma catecholamines and neuropeptidey levels in patients with pheochromocytoma: A placebo-controlled trial (1995) (9)
Dose Dependency of Captopril Effects in Severely Hypertensive Patients (1981) (9)
Phaeochromocytoma revealed by type A acute aortic dissection. (1994) (9)
Automated interpretation of home blood pressure assessment (Hy-Result software) versus physician’s assessment: a validation study (2016) (9)
HY-Quest, standardized patient questionnaire to be completed at home before a first visit for hypertension: a validation study in specialized centres in France (2014) (9)
Are angiotensin converting enzyme inhibition and aldosterone antagonism equivalent in hypertensive patients over fifty? (1991) (8)
Primary Aldosteronism vidence for an Increased Rate of Cardiovascular vents in Patients With Primary Aldosteronism (2005) (8)
[Tumors of both adrenal glands. 12 consecutive cases]. (1994) (8)
Hypokalemia, aldosteronism, and renal cysts. (1990) (8)
Deciphering the Role of Vasopressin in Primary Aldosteronism. (2015) (8)
Hypertension management: the role of the computer in improving patient compliance. (1982) (8)
[Hypertension and primary hyperaldosteronism]. (2000) (8)
[Arterial hypertension secondary to curable causes in adults]. (2002) (7)
[Hypertensive disease in subjects born in sub-Saharan Africa or in Europe referred to a hypertension unit: a cross-sectional study]. (2007) (7)
Building a Semantic Interoperability Framework for Care and Research in Fibromuscular Dysplasia (2015) (7)
[Logical basis for the diagnosis of renovascular hypertension. Application to the treatment of atheromatous stenosis of the renal arteries]. (1990) (7)
[Primary hyperaldosteronism: diagnostic value of the administration of a single dose of captopril]. (1983) (7)
Teletransmission of home blood pressure monitoring: making it easier. (2008) (6)
Automatic stenosis detection and quantification in renal arteriography (1997) (6)
A "pivot" Model to set up Large Scale Rare Diseases Information Systems: Application to the Fibromuscular Dysplasia Registry (2015) (6)
[Testing an expert system for hypertension]. (1986) (6)
[Results of the surgical treatment of Conn's adenomas]. (1987) (6)
About an epidemic of primary aldosteronism. (2008) (6)
[A simple diagnostic test for primary hyperaldosteronism]. (1983) (6)
[Update on endocrine hypertension]. (2012) (6)
Study of glucagon secretion using in vitro perifusion of rat pancreas pieces. (1975) (5)
CLINICAL PROFILE OF PATIENTS REFERRED TO A TERTIARY HYPERTENSION UNIT IN A CITY AREA: PP.15.52 (2010) (5)
Variations with time of plasma concentrations of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2. (2007) (5)
Masked hypertension : a systematic review. Commentary (2008) (5)
[Adrenocortical scintigraphy with 131I-19-iodocholesterol. Indications and results in 66 cases of hypercortisolism and hyperaldosteronism (author's transl)]. (1981) (5)
Stent treatment for pseudocoarctation and refractory hypertension in an elderly patient with Takayasu's arteritis. (2000) (5)
[Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial]. (1987) (5)
[Treatment of arterial hypertension. Comparative effectiveness of the day care hospital and classical hospitalization]. (1983) (5)
CO-43: Genetic study identifies common variation in phactr1 to associate with fibromuscular dysplasia. (2015) (5)
[Recent advances in the investigation of the renin-angiotensin and cardiac natriuretic systems in patients with chronic heart insufficiency]. (1991) (4)
[Incidence and fetal impact of hypertension in pregnancy: study of 2996 pregnancies]. (1982) (4)
Clinical and biochemical characterization of antithrombin III Franconville, a variant with Pro 41 Leu mutation (1990) (4)
Influence of educational and sociocultural factors on hypertension care. (1985) (4)
[Malignant adrenal cortex carcinoma revealed by an isolated picture of primary hyperaldosteronism]. (1988) (4)
Localizing value of catecholamine profile in patients with adrenal or ectopic pheochromocytoma. (1994) (4)
[A computerized medical record for the follow-up of hypertensive patients (author's transl)]. (1980) (4)
Abstract 15370: Genetic Study Identifies Common Variation in PHACTR1 to Associate With Fibromuscular Dysplasia (Best of Basic Science Abstract) (2015) (4)
Atherosclerotic renal artery stenosis: Surgery, percutaneous transluminal angioplasty, or medical therapy? (2000) (4)
[Evaluation of a computer assisted training program for hypertensive patients]. (1994) (4)
Epithelioid sarcoma of soft tissues: a case of extrarenal renin-secreting tumour. (1988) (4)
ESH-ENDORSED EUROPEAN/INTERNATIONAL FIBROMUSCULAR DYSPLASIA REGISTRY: RESULTS OF THE FIRST 609 PATIENTS (2018) (4)
CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM: A CONTROLLED CROSS-SECTIONAL STUDY: PP.18.178 (2010) (4)
[Renal artery fibromuscular dysplasia]. (2011) (4)
[Antinuclear antibodies and lupus induced during treatment of arterial hypertension. Role of beta-blockers and alpha-methyldopa]. (1983) (4)
Noradrenaline producing phaeochromocytomas with absent pressor response to beta-blockade. (1979) (4)
Male Sex Is Associated With Cervical Artery Dissection in Patients With Fibromuscular Dysplasia (2021) (4)
SELECTION OF PATIENTS FOR SURGERY FOR PRIMARY ALDOSTERONISM (2008) (4)
Renin Activity and the Response to Beta-Blockade (1981) (4)
Compliance to Antihypertensive Therapy (1982) (3)
[PP.25.14] RECURRENCE OR NEW TUMOURS AFTER COMPLETE RESECTION OF PHAEOCHROMOCYTOMAS AND PARAGANGLIOMAS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2016) (3)
In vitro glucocorticosteroid and mineralocorticosteroid biosynthesis in Conn’s adenoma tissues (1993) (3)
[Presentations and management of adrenal hypertension]. (2014) (3)
Test diagnostique simple de l'hyperaldostéronisme primaire. (1983) (3)
B013: Comparison of telmisartan monotherapy with losartan + HCTZ in mild-to-moderate hypertension (2000) (3)
[Renal-nerve ablation in patients with resistant hypertension: caution is still needed]. (2012) (3)
IMPACT OF DIAGNOSTIC CRITERIA ON THE INTERPRETATION OF ADRENAL VENOUS SAMPLING RESULTS: 4D.03 (2010) (3)
Renal artery stenosis and congestive heart failure. (1993) (3)
BLOOD PRESSURE AND POTASSIUM EFFECTS OF THE NEW DIRECT ALDOSTERONE SYNTHASE INHIBITOR, LCI699, IN PATIENTS WITH PRIMARY ALDOSTERONISM: 9D.03 (2010) (3)
[Value and limits of renal artery examination in the aged]. (1990) (3)
Effect of captopril and other inhibitors of angiotensin-converting enzyme on plasma prolidase activity. (1988) (3)
OMAPATRILAT IN PERSONS WITH ENHANCED RISK OF ATHEROSCLEROTIC EVENTS: THE OPERA TRIAL (2000) (3)
Influence of beta-blockade on aldosterone metabolism under normal and low sodium diet in man. (1977) (2)
COMPARISON OF TELMISARTAN MONOTHERAPHY WITH LOSARTAN + HYDROCHLOROTHIAZIDE IN MILD-TO-MODERATE HYPERTENSION: P2.33 (2000) (2)
Interactions between antihypertensive agents, serum lipids and cigarette smoking in high risk hypertensive patients. (1989) (2)
[Validation of an self-measurement blood pressure device]. (1988) (2)
[Predictive factors of resistance to antihypertensive treatment]. (1987) (2)
MANAGEMENT OF PHEOCHROMOCYTOMA – PARAGANGLIOMA (2019) (2)
Use of plasma chromogranin A and urine fractionated metanephrines to diagnose pheochromocytoma? (2008) (2)
[Revascularization of atherosclerotic stenosis of the renal artery. Indications and results]. (2001) (2)
THE SDHB AND VHL GENES SHOULD BE SYSTEMATICALLY TESTED IN PATIENTS WITH NONSYNDROMIC PHEOCHROMOCYTOMA: P2.207 (2004) (2)
[The Na+/H+ antiport: a target for new antihypertensive agents]. (1989) (2)
SUPERIORITY OF LOW DOSE DIURETICS COMBINATION OVER RENIN-ANGIOTENSIN BLOCKERS COMBINATION IN RESISTANT HYPERTENSION: PP.16.89 (2010) (2)
SERUM SODIUM TO URINARY SODIUM DIVIDED BY (SERUM POTASSIUM)2 TO URINARY POTASSIUM (SUSPPUP RATIO) AS A SCREENING TOOL FOR PRIMARY ALDOSTERONISM: PP.18.172 (2010) (2)
[Access to medical care of patient with hypertension: influence of socio-professional categories (author's transl)]. (1980) (2)
Renal artery stenosis and congestive heart failure (1993) (2)
[Renovascular hypertension: diagnostic and therapeutic strategy]. (1992) (2)
The importance of diabetes as a cardiovascular risk factor. (2000) (2)
[Comparison of 3 methods of blood pressure measurement in obesity]. (1988) (2)
[Pheochromocytoma and pregnancy. Case report]. (2006) (2)
H54: Efficacy and safety of candesartan cilexetil in combination with hydrochlorothiazide (HCTZ) in the treatment of patients with mild to moderate hypertension unresponsive to HCTZ alone (1997) (2)
Structural and functional arterial abnormalities in fibromuscular dysplasia are in the continuum of hypertension: an imaging and biomechanical study (2016) (2)
Pheochromocytoma of the Urinary Bladder (2002) (2)
Possible Implication of the Renin-Angiotensin-Aldosterone System in the Hypertension of Phaeochromocytoma (1985) (2)
The influence of diagnostic criteria on the interpretation of adrenal venous sampling (2014) (2)
[Critical evaluation of the functional signs of arterial hypertension]. (1982) (2)
[Achievements of the COMETE program in the genetics of pheochromocytoma]. (2008) (2)
[Renovascular arterial hypertension. Evaluation of ultrasonographic measurement of kidney length]. (1992) (2)
IgG versus albumin for measurement of plasma volume in normal and hypertensive men (1978) (1)
Abstract P137: Socioeconomic Status And Hypertension Control In Sub-saharan Africa: The Multination Eight Study (2018) (1)
CAPPP trial (1999) (1)
[From clinical observation to assessment of practices: guidelines for hypertension management]. (2009) (1)
REFRACTORY HYPERTENSION: EFFICACY AND SAFETY OF A TRIPLE DIURETIC ASSOCIATION (2004) (1)
Adrenal tumours and hormone excess. Editorial. (2009) (1)
Images in cardiovascular medicine. Pheochromocytoma of the urinary bladder. (2002) (1)
[Endocrine hypertension in pregnancy]. (2002) (1)
[Phaeochromocytoma: localisation by computerised scanner tomography. 5 cases (author's transl)]. (1979) (1)
ACE inhibitors and diabetics with albuminuria. The DIABHYCAR Study Group. (1995) (1)
Ethnicity and socio-economic inequalities in malignant hypertension. (2006) (1)
ACE inhibitors and diabetics with albuminuria (1995) (1)
ACE inhibitors, cough, and genetics. (1994) (1)
[Non-surgical treatments of renal artery stenoses]. (1996) (1)
The Antlhypertensive Effect of Nicardipine (Long-Acting Form), Renin Activity and Divalent Cations (1985) (1)
Sarcoidosis presenting as severe renin-dependent hypertension due to kidney vascular injury (2014) (1)
Chapter 66 – Renin-Secreting Tumors and Other Renin-Secreting States (2007) (1)
INFLUENCE OF RENAL ARTERY DENERVATION ON BLOOD PRESSURE VARIABILITY AND BAROREFLEX SENSITIVITY: A PROSPECTIVE CONSECUTIVE CASE-SERIES: 4A.06 (2011) (1)
5. Single intravenous nicardipine dose: a new diagnosis test in renovascular hypertension (1991) (1)
Transluminal vascular stents for ostial atherosclerotic renal artery stenosis (1995) (1)
[Comparison of the effect of captopril and minoxidil on left ventricular mass. Results of a 6-month comparative double-blind test]. (1987) (1)
[A new diagnostic test for primary tumoral hyperaldosteronism]. (1983) (1)
10 Evaluation of a computer‐assisted education program for hypertensive patients (1994) (1)
5. Split and global renal function in hypertensive patients following successful percutaneous transluminal renal angioplasty for unilateral renal artery stenosis (1995) (1)
[Transluminal angioplasty in renovascular hypertension with renal insufficiency]. (1988) (1)
RARE LOSS-OF-FUNCTION MUTATIONS OF PTGIR IDENTIFIED IN FIBROMUSCULAR DYSPLASIA AND SPONTANEOUS CORONARY ARTERY DISSECTION (2019) (1)
β-Adrenoceptor Blocking Drugs and the Renin-Angiotensin System (1980) (1)
[Antihypertensive drugs prescribed to patients before their first consultation in a hypertension unit: comparison between 2001 and 2006]. (2008) (1)
Fuzzy classification of renal artery lesions from angiograms in the context of angioplasty. (1997) (1)
The ARTEMIS data and knowledge base for hypertension (1991) (1)
Urgences hypertensives de l'adulte (2010) (1)
[Acute response to calcium inhibitors in secondary arterial hypertension: does renin play a role?]. (1988) (1)
Prevalence and etiologies of endocrine hypertension (2006) (1)
THE ADRENAL VEIN SAMPLING INTERNATIONAL STUDY (AVIS) ON USE AND INTERPRETATION OF ADRENAL VEIN SAMPLING FOR DIFFERENTIATING THE MAJOR SUBTYPES OF PRIMARY ALDOSTERONISM: 8D.07 (2011) (1)
[Left ventricular involvement in Conn adenoma, renovascular hypertension and pheochromocytoma before and after etiological treatment]. (1992) (1)
Differential transcription of 11[beta]-hydroxylase and aldosterone synthase alleles in human adrenocortical tissue (2009) (1)
HORMONAL EFFECTS OF THE NEW DIRECT ALDOSTERONE SYNTHASE INHIBITOR, LCI699, IN PATIENTS WITH PRIMARY ALDOSTERONISM: 5C.06 (2010) (1)
[Hypertensive emergencies in adults: a practical review]. (2010) (0)
Response to implementation of rapid cortisol during adrenal vein sampling. (2014) (0)
[Coronary disease prevention in diabetic hypertension: intervention thresholds and therapeutic methods]. (1997) (0)
[Management of atherosclerotic renal artery stenoses]. (2002) (0)
[Is reversal of left ventricular hypertrophy a priority in patients with hypertension?]. (1995) (0)
[PP.07.07] CIRCULATING MICROVESICLES (C-MVS) LEVELS AND ENDOTHELIAL FUNCTION IN PATIENTS WITH MULTIFOCAL FIBROMUSCULAR DYSPLASIA (FMD): A CROSS-SECTIONAL STUDY (2016) (0)
[OP.1C.06] HIGH PREVALENCE OF MULTISITE FIBROMUSCULAR DYSPLASIA: THE ARCADIA (ASSESSMENT OF RENAL AND CERVICAL ARTERY DYSPLASIA) REGISTRY (2016) (0)
Potential role of mast cells in the physiopathology of aldosterone-producing adenoma (2011) (0)
[The beta-blockers in hypertension]. (1984) (0)
Experimental Assessment of the Role of an Expert System in Hypertension (1986) (0)
[Pharmacology of converting enzyme inhibitors (captopril and related products)]. (1982) (0)
[PP.25.17] EFFECT OF RENAL ARTERY ANGIOPLASTY ON AMBULATORY BLOOD PRESSURE IN PATIENTS WITH RESISTANT HYPERTENSION AND ATHEROSCLEROTIC RENAL ARTERY STENOSIS (2017) (0)
Un exemple d'association acceptable dans le traitement de l'hypertension artérielle. (1978) (0)
[Incidence of beta-blockers on plasma renin activity. Present status]. (1978) (0)
Progression-free survival without treatment of malignant pheochromocytoma and paraganglioma at one year (2012) (0)
45th ESCP-NSF international symposium on clinical pharmacy: clinical pharmacy tackling inequalities and access to health care. Oslo, Norway, 5–7 October 2016 (2017) (0)
OS 04-02 HIGH PREVALENCE OF MULTISITE FIBROMUSCULAR DYSPLASIA: THE ARCADIA REGISTRY. (2016) (0)
[The individual risk of hypertensive patients: from assessment to treatment. Comments on the first session]. (1997) (0)
Hypertension in Practice (2000) (0)
[Effects of acebutolol on the renin-aldosterone system in essential arterial hypertension]. (1975) (0)
[Cervical and intracranial fibromuscular dysplasia]. (2011) (0)
Patient Compliance in Hypertension Care: The Critical Role of the Computer (1982) (0)
Iconography : Hypertension artérielle endocrine (2010) (0)
Malignant pheochromocytomas or paragangliomas (2010) (0)
Scintigraphie surrénale : Resultats dans les hyperaldostéronismes primaires et les hypercortisolismes à propos de 62 casAdrenal scanning: Results in 62 subjects with primary hyperaldosteronism and hypercortisolism (1980) (0)
FEASIBILITY OF ESTIMATING FIBROMUSCULAR DYSPLASIA PREVALENCE USING HEALTH ADMINISTRATIVE DATABASE: A NATIONWIDE STUDY (2018) (0)
Phaeochromocytoma as presenting manifestation of Von Hippel-Lindau disease: (1992) (0)
[Diuretics in arterial hypertension]. (1986) (0)
15th Meeting of the French Hypertension Society Palais des Congrès, Paris, 14–15 December 1995: Comparative study of traditional and endoscopic surgery of Conn's adenoma (1997) (0)
[Medico social management of severe hypertension]. (2013) (0)
[Interest in multifactorial prevention of coronary disease in hypertensives: use of beta blockaders]. (1979) (0)
[The decision to treat moderate hypertension: repetition of office visits or ambulatory monitoring of arterial pressure?]. (1987) (0)
Abstract No. 31: Catheter-based renal sympathetic denervation for the treatment of uncontrolled hypertension: An overview of technology, technique and recent clinical experience (2011) (0)
[Use of beta blockaders in the treatment of arterial hypertension]. (1975) (0)
[Plasma renin and noradrenalin levels during hypotensive therapy using acebutolol (author's transl)]. (1979) (0)
[Giant pheochromocytoma mimicking hepatoma]. (1980) (0)
Angioplasty vs medical therapy in the treatment of unilateral atherosclerotic renal artery stenosis: A prospective randomized open blinded-endpoint trial (1997) (0)
Prevalence and Determinants of Non-rheumatic Atrial Fibrillation (AF) in Patients With Primary Aldosteronism (1998) (0)
Response to Metabolic Dysfunction in Primary Aldosteronism (2009) (0)
[Influence of sex hormones on the arterial pressure]. (1994) (0)
MANAGEMENT OF PHEOCHROMOCYTOMAñPARAGANGLIOMA (2010) (0)
[Management of hypertensive crises and refractory hypertension]. (1990) (0)
Noradrenaline producing phaeochromocytomas with (1979) (0)
[Hypertension of adrenal origin: the experience of a medicosurgical team from 1975 to 1979]. (1980) (0)
Human Cancer Biology MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma (2012) (0)
[Hypertension excellence centers]. (2010) (0)
[Does hypertension have fewer complications in pregnancy in obese patients?]. (1987) (0)
PREDICTIVE FACTORS OF BLOOD PRESSURE CONTROL IN RESISTANT HYPERTENSION TREATED BY SEQUENTIAL NEPHRON BLOCKADE VS SEQUENTIAL RENIN ANGIOTENSIN SYSTEM BLOCKADE: 9A.04 (2011) (0)
CAPPP trial. Captopril Prevention Project. (1999) (0)
[Treatment of hypertension: present and perspectives]. (2012) (0)
[Endocrine hypertension]. (2010) (0)
Management of phaeochromocytomas and paragangiolomas (2011) (0)
FEATURES AT PRESENTATION AND RISK OF RECURRENCE IN PATIENTS WITH PHEOCHROMOCYTOMA: P2.116 (2004) (0)
[The evaluation of arterial hypertension in a patient with arteritis is central to the assessment of renal artery stenosis]. (2005) (0)
CO-14: Assessment of patients attending hypertension consultations at University Hospital Georges Pompidou in the last 15 years. (2015) (0)
[Fibromuscular dysplasia]. (2007) (0)
VIDEO TRAINING FOR BLOOD-PRESSURE SELF-MEASUREMENT: P2.18 (2004) (0)
[Arterial hypertension and social inequalities]. (1979) (0)
Reply: diagnosis and management of fibromuscular dysplasia. (2014) (0)
[Is it still necessary to look for the surgically-treatable causes of arterial hypertension?]. (1981) (0)
[Arterial hypertension: risk factor in atheroma]. (1982) (0)
the(causative)relationshipbetweenanatomicalabnormali- ties and changes in renal function. (2014) (0)
[Can we reduce the cardiovascular risk in hypertensive patients?]. (1998) (0)
OS 04-02 HIGH PREVALENCE OF MULTISITE FIBROMUSCULAR DYSPLASIA: THE ARCADIA REGISTRY (2016) (0)
[Indication and choice of diuretic treatment]. (1978) (0)
Subject Index Vol. 58, 2000 (2000) (0)
[Calcium inhibitors and treatment of arterial hypertension]. (1988) (0)
[Adrenal hypertension]. (2008) (0)
Points: A plain man's guide to the management of migraine (1982) (0)
[When and how to undertake antihypertensive treatment in a diabetic]. (1993) (0)
[Renovascular hypertension. Concepts and reality]. (1979) (0)
High Blood Pressure and the Risk of Stroke (2006) (0)
Common carotid artery wall subclinical lesions are present in subjects with renal fibromuscular dysplasia (2012) (0)
[Kidneys, hypertension and pregnancy. I. Renal function in normal pregnancy (author's transl)]. (1982) (0)
[Should angioplasty still be considered for atherosclerotic renal artery stenosis?]. (2001) (0)
[Monitoring of diuretic treatment. Research on complications]. (1978) (0)
Polymorphic variation in the aldosterone synthase gene (CYP11B2) in aldosterone-producing adenomas (2000) (0)
Q001: The answer to “What is my BP, doctor?” Depends on whom is asked (1998) (0)
[With which drug should the general practitioner begin antihypertensive treatment: a diuretic of a beta blocker?]. (1977) (0)
Optimal management of hypertensive patients with LVH and dyslipidaemia. (1998) (0)
[Disorders of carbohydrate metabolism induced by steroid contraceptive agents]. (1975) (0)
[Current clinical use of converting enzyme inhibitors]. (1982) (0)
Spectre clinique de lhyperaldostronisme primaire: tude dune cohorte franaise de 124 patients (1997) (0)
[Use of intravenous nicardipine for the diagnosis of renovascular hypertension]. (1991) (0)
The relationship between functional arterial response and circulating biomarkers of patients with fibromuscular dysplasia (2016) (0)
[Angioplasty for atherosclerotic renal artery stenosis: the end of the story?]. (2014) (0)
THE HIF-PATHWAY, NEW CANDIDATE GENES FOR PARAGANGLIOMA AND/OR PHEOCHROMOCYTOMA?: P1.201 (2004) (0)
B9 - Plasma levels of potassium, aldosterone, renin, and the aldosterone/renin ratio in patients with aldosterone-producing adenoma: Relation to diagnosis and blood pressure outcome (1995) (0)
J10 Left ventricular mass and radial artery wall thickness in primary aldosteronism (PA) and essential hypertension (EH) (1997) (0)
[Iodo-methyl norcholesterol scintigraphy in the localization of primary hyperaldosteronism]. (1989) (0)
HOME SELF BLOOD-PRESSURE MEASUREMENT: PATIENT EXPERIENCES (2004) (0)
[Plasma renin and catecholamine activity in pheochromocytoma]. (1985) (0)
[Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications]. (1984) (0)
Optimisation du test génétique du phéochromocytome : détection des remaniements de grande taille par QMPSF (quantitative multiplex PCR of short fluorescent fragments) (2007) (0)
ISIS: a computer-assisted education program for hypertensive patients and patients at cardiovascular risk (1994) (0)
[Residual arterial hypertension after excision of an extra-adrenal pheochromocytoma]. (1986) (0)
[Relations between family history of essential hypertension and fetal prognosis in hypertension in pregnancy]. (1989) (0)
INVESTIGATION OF THE 9P21 LOCUS AS A SUSCEPTIBLE LOCUS FOR RENAL ARTERIAL FIBROMUSCULAR DYSPLASIA: 9D.02 (2011) (0)
[Alpha-blockers in practice: classification and therapeutic use]. (1981) (0)
Evaluation of a standardized protocol for the collection and storage of adrenal tumor samples preparation for an European adrenal tumor bank (ENS@T) (2006) (0)
CHARACTERISTICS OF CONTROLLED VS. RESISTANT ESSENTIAL HYPERTENSIVE PATIENTS AFTER A STANDARDIZED 4-WEEK THREE DRUG-REGIMEN: PP.43.372 (2011) (0)
Comparison Trial of Drug Intervention and Dietary Intervention in Overweight Hypertensive Patients (1986) (0)
[Arterial hypertension: a specialty of the general practitioner]. (1979) (0)
[Simultaneous measurement of cardiac output by indium 113 m detected externally and by dye dilution of indocyanine green]. (1977) (0)
[Effects of minoxidil on blood pressure and plasma volume in refractory hypertension (author's transl)]. (1979) (0)
Low angiotensinogen levels as an index of severity in heart failure. Consequence for renin measurement (1990) (0)
[Labile hypertension (author's transl)]. (1977) (0)
[Diuretics and cardiovascular outcome in hypertensive patients: an update]. (2003) (0)
[Primary hyperaldosteronism]. (1998) (0)
Does stenting for atherosclerotic renovascular disease improve blood pressure and kidney function better than medical treatment? (2009) (0)
P-591: Effects of slow-release octreotide in patients with malignant or recurrent pheochromocytoma (2003) (0)
[Fibromuscular dysplasia of renal arteries]. (2016) (0)
[Blood pressure auto-measurement]. (1981) (0)
[From sclerosis to vascular risk. The unknown contribution of life insurance]. (1994) (0)
[Why look for secondary hypertension?]. (2015) (0)
[Patients operated on for pheochromocytoma: biological surveillance]. (1999) (0)
In-Depth Review Atherosclerotic renovascular disease: beyond the renal artery stenosis (2007) (0)
Masked hypertension: a syste matic review (2008) (0)
HYPERTENSION FOLLOWING RENAL TRAUMA: PREVALENCE, PRESENTATION AND OUTCOME (2004) (0)
Aldosterone changes during angiotensin III and potassium infusions in patients with primary aldosteronism (1996) (0)
The application of molecular genetics to the study of familial arterial hypertension. (1989) (0)
[Recent development of recommendations for the screening and treatment of arterial hypertension]. (2002) (0)
BIOCHEMICAL DIAGNOSIS OF PHEOCHROMOCYTOMA: COMPARISON OF URINARY METANEPHRINES WITH FREE AND TOTAL PLASMA METANEPHRINES (2004) (0)
[Kidneys; hypertension and pregnancy. III. The renal risk in pregnancy]. (1982) (0)
Abstract 49: Male Sex is Associated With Cervical Artery Dissection in Patients With Fibromuscular Dysplasia (2020) (0)
Reviewucing adenoma and other surgically correctable forms of primary aldosteronism (2010) (0)
0382 : Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia (2015) (0)
[Detection of silent ischemia in hypertensive subjects with high vascular risk using continuous electrocardiogram in real time]. (1989) (0)
Magnetic Resonance Imaging in Adrenal Hypertension: Preliminary Results in 21 Patients (1986) (0)
[The treatment of hypertension in pregnancy (author's transl)]. (1982) (0)
[The treatment of hypertension: long-term strategy]. (1979) (0)
VASOPEPTIDASE-INHIBITOR OMAPATRILAT (1999) (0)
Detection of large rearrangements in the pheochromocytomas genes using QMPSF (quantitative multiplex PCR of short fluorescent fragments): improvement of genetic testing (2007) (0)
[Effect of alpha inhibitors on risk cofactors in patients with hypertension]. (1989) (0)
[Hypertension, catecholamine hypersecretion and potential for metastasis: recent progress in the pathophysiology and genetics of pheochromocytoma and paraganglioma]. (2015) (0)
[Influence of recent trials on essential arterial hypertension management]. (2004) (0)
H44 Effect of antihypertensive therapy on cognitive function, mood and quality of life in elderly patients: A comparison of ramipril with nitrendipine (1997) (0)
Isolated Clinical Syndrome of Primary Aldosteronism in Four Patients With Adrenocortical Carcinoma (1988) (0)
A RETROSPECTIVE STUDY ON THE TAILORING OF SCORE CHARTS IN A SPECIALIZED TERTIARY HYPERTENSION UNIT (2018) (0)
[Measurement of platelet catecholamine content for the diagnosis of pheochromocytoma with intermittent hypertension]. (1987) (0)
[OP.7C.04] GENETIC ASSOCIATION STUDY IDENTIFIES COMMON VARIATION IN PHACTR1 TO ASSOCIATE WITH FIBROMUSCULAR DYSPLASIA (2016) (0)
[The renin-angiotensin system and its inhibition (author's transl)]. (1981) (0)
[Kidneys, hypertension and pregnancy. II. Hypertension in pregnancy: significance, prognosis, and treatment (author's transl)]. (1982) (0)
[An example of an acceptable combination in the treatment of arterial hypertension]. (1978) (0)
[Pheochromocytoma: 25 years of experience. Report of 199 cases]. (2003) (0)
Autocrine-paracrine pathways in primary adrenal disorders (2007) (0)
Beneficial effect of sequential nephron blockade of central pressure and large artery remodelling in resistant hypertension (2013) (0)
BLOOD PRESSURE OUTCOME FOLLOWING ACUTE SEGMENTAL RENAL INFARCTION: P1.210 (2004) (0)
COMPARISON OF BLOOD PRESSURE, POTASSIUM, RENIN AND ALDOSTERONE EFFECTS OF ALDOSTERONE SYNTHASE INHIBITION VS. MINERALOCORTICOID BLOCKADE IN PATIENTS WITH PRIMARY ALDOSTERONISM: 4A.02 (2011) (0)
GENETIC STUDY OF PHACTR1 AND FIBROMUSCULAR DYSPLASIA, META-ANALYSIS AND EFFECTS ON CLINICAL FEATURES OF PATIENTS (2019) (0)
[Recommendations for the management of patients with severe arterial hypertension. Commission IV. Cardiovascular Diseases]. (2012) (0)
Apports de COMETE à la génétique du phéochromocytome. Discussion (2008) (0)
Contents Vol. 58, 2000 (2000) (0)

This paper list is powered by the following services:

Pierre‐françois Plouin's Academic­Influence.com Rankings

Pierre‐françois Plouin's Degrees

Why Is Pierre‐françois Plouin Influential?

Pierre‐françois Plouin's Published Works

Published Works

Pierre‐françois Plouin's AcademicInfluence.com Rankings